Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A lyophilized (freeze-dried) black raspberry functional food product developed by the Ohio State University Comprehensive Cancer Center for cancer prevention research, specifically in patients with prostate cancer. The intervention delivers concentrated phytochemicals, including anthocyanins (such as cyanidin-3-rutinoside) and ellagitannins, which are metabolized into bioactive compounds like protocatechuic acid and urolithin A. It is administered in formulations such as gummy confections or nectar. The product aims to modulate biological pathways involved in cancer progression, including lowering insulin-like growth factor-I (IGF-I) and androgen levels, while increasing IGF-binding protein 3 (IGF-BP3) and exerting anti-inflammatory and antioxidant effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lyophilized black raspberry.